Robert Michael Dudley - Sep 28, 2023 Form 4 Insider Report for Transcode Therapeutics, Inc. (RNAZ)

Role
Chief Executive Officer, Director
Signature
/s/ Thomas A. Fitzgerald, Attorney-in-Fact
Stock symbol
RNAZ
Transactions as of
Sep 28, 2023
Transactions value $
$49,980
Form type
4
Date filed
10/2/2023, 04:37 PM
Previous filing
Jun 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAZ Common Stock Purchase $50K +98K +119.13% $0.51 180K Sep 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer.